Organigram (OGI) Competitors

Canopy Growth (TSE:WEED) and Organigram (TSE:OGI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, community ranking, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

Which has higher earnings and valuation, WEED or OGI?

Organigram has lower revenue, but higher earnings than Canopy Growth. Organigram is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	C$362.24M	2.07	-C$1.18B	-C$21.30	-0.47
Organigram	C$149.21M	1.51	-C$229.48M	-C$2.51	-0.87

Does the MarketBeat Community favor WEED or OGI?

Canopy Growth received 593 more outperform votes than Organigram when rated by MarketBeat users. Likewise, 62.32% of users gave Canopy Growth an outperform vote while only 44.34% of users gave Organigram an outperform vote.

Company	Underperform	Outperform
Canopy Growth	Outperform Votes 640 62.32%	Underperform Votes 387 37.68%
Organigram	Outperform Votes 47 44.34%	Underperform Votes 59 55.66%

Does the media refer more to WEED or OGI?

In the previous week, Canopy Growth had 3 more articles in the media than Organigram. MarketBeat recorded 3 mentions for Canopy Growth and 0 mentions for Organigram. Organigram's average media sentiment score of 1.12 beat Canopy Growth's score of 0.00 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Overall Sentiment
Canopy Growth	Positive
Organigram	Neutral

Which has more risk & volatility, WEED or OGI?

Canopy Growth has a beta of 1.85, indicating that its stock price is 85% more volatile than the S&P 500. Comparatively, Organigram has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500.

Do analysts rate WEED or OGI?

Canopy Growth presently has a consensus target price of C$5.40, indicating a potential downside of 45.89%. Organigram has a consensus target price of C$3.76, indicating a potential upside of 70.83%. Given Canopy Growth's stronger consensus rating and higher probable upside, analysts clearly believe Organigram is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Organigram	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Is WEED or OGI more profitable?

Canopy Growth has a net margin of 0.00% compared to Canopy Growth's net margin of -153.80%. Canopy Growth's return on equity of -54.53% beat Organigram's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	N/A	-121.56%	-8.89%
Organigram	-153.80%	-54.53%	-5.56%

Do institutionals & insiders have more ownership in WEED or OGI?

14.0% of Canopy Growth shares are owned by institutional investors. Comparatively, 12.2% of Organigram shares are owned by institutional investors. 0.3% of Canopy Growth shares are owned by company insiders. Comparatively, 27.3% of Organigram shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Canopy Growth beats Organigram on 10 of the 18 factors compared between the two stocks.